ADAR1 as a Placental Innate Immune Rheostat Sustaining the Homeostatic Balance of Intrinsic Interferon Response at the Maternal‐Fetal Interface
Advanced Science · 2025
DOI: 10.1002/advs.202505491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaogang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Reproductive Health Research, Cancer Research Center, Department of Obstetrics and Gynecology, Women and Children…. Hauptthemen laut MEDLINE: Adenosine Deaminase, Placenta, Immunity, Innate, Interferons. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Sciences Foundation in China, National Key Research and Development Program of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The mechanisms that balance a robust intrinsic antiviral defense at the maternal‐fetal interface with fetal development remain elusive. Here, it is delineated that ADAR1, an adenosine‐to‐inosine (A‐to‐I) editor, fine‐tunes intrinsic interferon (IFN)‐mediated integrates stress response (ISR) in the mouse placenta, thereby orchestrating embryonic development and antiviral defense. Placental Adar1 deletion ( Adar1 PKO ) trigger spatially resolved overwhelming IFN responses, which impair the differentiation of IFN hyper‐responsive junctional zone (JZ) progenitors and functions of the placental JZ, ultimately causing embryonic death. Mechanistically, the Adar1 PKO placental IFN hyper‐response is positively amplified by the accumulated immunogenic dsRNAs from the 3′UTR of interferon‐stimulated genes (ISG‐3′UTR‐dsRNA). The resulting fetal death is rescued by concurrent deletion of Mavs , Ifnar1 , or Pkr , but not Zbp1 or cell death effectors. Notably, blocking ISR pharmacologically preventes embryonic lethality induced by Adar1 PKO JZ defects. These findings demonstrate that ADAR1 fine‐tunes the unique spatially resolved IFN‐PKR‐ISR signaling in the placenta by restricting ISG‐3′UTR‐dsRNA accumulation, highlighting a potential therapeutic strategy for treating interferonopathy‐associated pregnancy complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Reproductive Health Research, Cancer Research Center, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, 36…
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, 361102, China.
ORCID-Profile: Bin Cao
Förderung
- National Natural Sciences Foundation in China
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- Scientific Research Foundation of State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory
- Xiamen University Double Frist Class Construction Project (Biology)
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Chen, X., Xu, X., Chen, J., Zhang, H., Zheng, W., Yu, W., Hu, X., & Cao, B. (2025). ADAR1 as a Placental Innate Immune Rheostat Sustaining the Homeostatic Balance of Intrinsic Interferon Response at the Maternal‐Fetal Interface. Advanced Science. https://doi.org/10.1002/advs.202505491
Vancouver
Chen X, Xu X, Chen J, Zhang H, Zheng W, Yu W, et al. ADAR1 as a Placental Innate Immune Rheostat Sustaining the Homeostatic Balance of Intrinsic Interferon Response at the Maternal‐Fetal Interface. Advanced Science. 2025. doi:10.1002/advs.202505491
BibTeX
@article{Chen2025,
author = {Chen, Xiaogang and Xu, Xiangchao and Chen, Jiahao and Zhang, Huiru and Zheng, Wanshan and Yu, Wenzhe and Hu, Xiaoqian and Cao, Bin},
title = {ADAR1 as a Placental Innate Immune Rheostat Sustaining the Homeostatic Balance of Intrinsic Interferon Response at the Maternal‐Fetal Interface},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202505491}
}
EUVIMED